Timothy Rifenberg, in Laguna Niquel, CA - Pharmacist

Timothy Rifenberg, is a Pharmacist based in Laguna Niquel, California. Timothy Rifenberg is licensed to practice in California (license number RPH33404) and his current practice location is 27470 Alicia Parkway, Laguna Niquel, California. He can be reached at his office (for appointments etc.) via phone at (949) 360-0923.

NPI number for Timothy Rifenberg is 1861801615 and his current mailing address is 27470 Alicia Parkway, Laguna Niquel, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1861801615.

Contact Information

	Timothy Rifenberg,
	27470 Alicia Parkway, Laguna Niquel, CA 92677
	(949) 360-0923
	Not Available

Healthcare Provider's Profile

Full Name	Timothy Rifenberg
Gender	Male
Speciality	Pharmacist
Location	27470 Alicia Parkway, Laguna Niquel, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1861801615
Provider Enumeration Date: 08/06/2014
Last Update Date: 08/06/2014

Medical Identifiers

Medical identifiers for Timothy Rifenberg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861801615	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	RPH33404 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Timothy Rifenberg is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Timothy Rifenberg, 27470 Alicia Parkway, Laguna Niquel, CA 92677 Ph: (949) 360-0923	Timothy Rifenberg, 27470 Alicia Parkway, Laguna Niquel, CA 92677 Ph: (949) 360-0923

News Archive

VisionCare's Implantable Miniature Telescope gets FDA approval for treating end-stage AMD

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older.

Women with acute coronary syndrome less likely to have chest pain than men

A higher proportion of women than men 55 years and younger did not have chest pain in acute coronary syndromes (ACS, such as heart attacks or unstable angina), although chest pain was the most common symptom for both sexes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

Highly active antiretroviral therapy (HAART) equally effective in patients with or without history of injection drug use

Highly active antiretroviral therapy (HAART) has been extremely effective at slowing the progression of HIV infection to AIDS as well as extending the lives and improving the quality of life for those with HIV. However, some doctors have been reluctant to prescribe HAART to HIV-infected injection drug users because of concern that they may not fully benefit from the therapy.

Different characteristics associated with depression before and after giving birth

Depression during pregnancy and following childbirth (perinatal depression) is a common and potentially severe condition. In a Journal of Neuroscience Research study, researchers examined subgroups of women followed from pregnancy to six months postpartum, for example comparing those with depression only after childbirth with those experiencing depression during pregnancy.

Experts call for mandatory helmet use at all positions of youth baseball and softball

Despite lower rates of traumatic brain injuries in baseball and softball, there is poor compliance overall with helmet use and return-to-play guidelines following a concussion across all levels of play, according to a new systematic review.

Timothy Rifenberg, - Pharmacist in Laguna Niquel, CA